Obesity Breakthrough: $3 Monthly Jab Offers Hope Worldwide
New analysis shows diabetes and obesity drug semaglutide could be made for just $3 per month, potentially reaching millions with cheap, effective treatment as patents expire.
A groundbreaking study has revealed that the weight-loss drug semaglutide, found in popular medications like Ozempic and Wegovy, could potentially be produced for just $3 per month. This discovery holds immense promise for millions of people worldwide struggling with diabetes and obesity, as the availability of affordable treatment options could significantly improve global health outcomes.
Obesity has become a global epidemic, with more than a billion people worldwide now living with the condition. The problem is particularly acute in lower-income nations, where the shift to westernized diets and more sedentary lifestyles has led to a rapid rise in obesity rates.
{{IMAGE_PLACEHOLDER}}Source: The Guardian
